AMIR RIZVI: Open Payments
NPI 1992806129 · WEST TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 23 payments from 8 companies in 2025. Trend: 2023 $133 · 2024 $220 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
| Otsuka America Pharmaceutical, Inc. | 7 | $118 |
| Teva Pharmaceuticals USA, Inc. | 6 | $103 |
| Lundbeck LLC | 4 | $78 |
| ABBVIE INC. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
Products named: COBENFY, ABILIFY MAINTENA, UZEDY, REXULTI, VRAYLAR, SPRAVATO, ERZOFRI EXTENDED-RELEASE, ARISTADA.
Industry payments across NJ — which companies pay providers there.
